Assenagon Asset Management
MD icon

Assenagon Asset Management’s Pediatrix Medical MD Stock Holding History

Assenagon Asset Management’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-201,845
Closed -$4.57M – 866
2019
Q3 		$4.57M Buy
+201,845
New +$4.6M 0.03% 255

Other funds holding MD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
PCP
P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return
SV
Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Assenagon Asset Management's MD Position: Q4 2019 in Review

Assenagon Asset Management sold out of Pediatrix Medical (MD) in Q4 2019, closing a stake of 201,845 shares — an estimated $4.57M sold.

Assenagon Asset Management first reported a position in MD in Q3 2019 and held it in 1 quarter. The position peaked at $4.57M in Q3 2019. 258 funds tracked by Wall St. Rank hold MD as of Q4 2019.

  • Assenagon Asset Management reported no remaining Pediatrix Medical position as of Q4 2019 after selling out during the quarter.
  • Assenagon Asset Management sold 201,845 Pediatrix Medical shares in Q4 2019, an estimated $4.57M.
  • Assenagon Asset Management first reported a position in Pediatrix Medical in Q3 2019 and held it in 1 quarter.
  • Assenagon Asset Management's Pediatrix Medical position peaked at $4.57M in Q3 2019.
  • 258 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2019.

Based on Assenagon Asset Management's 13F filing for Q4 2019, filed 17 Jan 2020.